that last quote seems strange to me. There are certainly instances where fast followers price lower and got significant share. The hepatitis c market is a good

that last quote seems strange to me. There are certainly instances where fast followers price lower and got significant share. The hepatitis c market is a good recent example. Gilead had the first drug and then two other companies followed shortly thereafter pricing at ~20-50% discounts and got significant share